Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Stair-edge contrast designs for older adults with vision impairment

Official title: Frequency of Contrast Enhancement on Stairways

Run by The University of Alabama in Huntsville · NCT07337317 · Data updated 2026-11-12

This project will test whether changing the contrast frequency on stair tread edges affects how older adults with and without vision impairment lift their feet when going up and down stairs.

More Mobility Limitation trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment65 (estimated)
SponsorThe University of Alabama in Huntsville
Academic / other
Locations1 site (Huntsville, Alabama)
StatusRecruiting
StartedJanuary 22, 2026
Main results expectedJanuary 2027
Study endsJuly 2027
Registry record updatedMay 1, 2026
Trial IDNCT07337317 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are older adults who travel independently in the community (including stairways at least twice per week), have contrast sensitivity of log 1.6 or better, and can safely ascend and descend stairs with rest as needed.

Probably not a fit

Patients who cannot use stairs safely or who have severe rheumatologic or orthopedic disease, recent lower-limb injury or joint replacement within six months are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will measure participants' vision and have them ascend and descend laboratory stairs with different contrast frequencies applied to the step tread edges. Foot clearance measurements will be recorded as markers of fall risk and compared between older adults with and without visual impairment across the different contrast conditions. Most participants will complete a single in-person visit for vision testing and stair trials, and an optional second visit will gather participant feedback in a focus group about how contrast affects mobility in daily life. The protocol isolates contrast spatial frequency on tread edges rather than other stair modifications to determine visual effects on stair negotiation.

Why it matters

Potential benefit: If successful, optimized contrast patterns on stair edges could improve foot clearance and reduce fall risk for older adults with vision impairment.

How similar studies have gone: Previous work shows that high-contrast step markings can improve stair visibility and safety, but manipulating contrast spatial frequency on tread edges is a newer approach with limited direct testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. ≥ Contrast sensitivity log 1.6 or greater
2. travels independently in the community, including stairways \> two times/week
3. comfortable ascending and descending a stairway with rest time provided

   Exclusion Criteria:
4. severe rheumatologic and or orthopedic diseases (e.g., awaiting joint replacement, active inflammatory disease)
5. lower-limb injuries and/or recent joint replacements (e.g., hip fracture, hip, or knee replacement within six months of study enrollment)

Where it's running

  • University of Alabama in Huntsville
    Huntsville, Alabama, United States
    Recruiting

Study contacts

  • Principal investigator: Sara A Harper, PhD — University of Alabama in Huntsville
  • Study coordinator: Sara A Harper, PhD
  • Email: sah0075@uah.edu
  • Phone: 2568242184

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.